BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 55969)

  • 21. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function.
    Geotzl EJ; Austen KF
    Monogr Allergy; 1977; 12():189-97. PubMed ID: 335214
    [No Abstract]   [Full Text] [Related]  

  • 22. Cold urticaria. Dissociation of cold-evoked histamine release and urticara following cold challenge.
    Keahey TM; Greaves MW
    Arch Dermatol; 1980 Feb; 116(2):174-7. PubMed ID: 6153520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue.
    Austen KF
    Fed Proc; 1974 Nov; 33(11):2256-62. PubMed ID: 4139041
    [No Abstract]   [Full Text] [Related]  

  • 24. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes.
    Immunology; 1976 Nov; 31(5):797-802. PubMed ID: 992712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urticaria and angioedema.
    Sheffer AL
    N Y State J Med; 1972 Apr; 72(8):922-8. PubMed ID: 4111913
    [No Abstract]   [Full Text] [Related]  

  • 26. Exercise-induced allergies: the role of histamine release.
    Silvers WS
    Ann Allergy; 1992 Jan; 68(1):58-63. PubMed ID: 1371041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of platelet-activating factor with primary acquired cold urticaria.
    Grandel KE; Farr RS; Wanderer AA; Eisenstadt TC; Wasserman SI
    N Engl J Med; 1985 Aug; 313(7):405-9. PubMed ID: 2410790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediator release in local heat urticaria.
    Atkins PC; Zweiman B
    J Allergy Clin Immunol; 1981 Oct; 68(4):286-9. PubMed ID: 7288047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.
    Boyce JA
    J Allergy Clin Immunol; 2006 Jun; 117(6):1415-8. PubMed ID: 16751006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system.
    Kay AB
    Antibiot Chemother (1971); 1974; 19():271-83. PubMed ID: 4142850
    [No Abstract]   [Full Text] [Related]  

  • 31. Exercise-induced urticaria and anaphylaxis.
    Stephansson E; Koskimies S; Lokki ML
    Acta Derm Venereol; 1991; 71(2):138-42. PubMed ID: 1675522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ablation of eosinophils on immediate-type hypersensitivity reactions.
    Gleich GJ; Olson GM; Loegering DA
    Immunology; 1979 Oct; 38(2):343-53. PubMed ID: 92457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective release of eosinophil chemotactic factor from peripheral leukocytes in patients with chronic urticaria.
    Czarnetzki BM; Kern F; Lichtenstein LM
    J Invest Dermatol; 1976 Aug; 67(2):276-8. PubMed ID: 59786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cold urticaria.
    Lin RY; Janniger CK; Schwartz RA; Lambert WC
    Am Fam Physician; 1986 Feb; 33(2):145-50. PubMed ID: 2868642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.
    Piliponsky AM; Pickholtz D; Gleich GJ; Levi-Schaffer F
    J Allergy Clin Immunol; 2001 Jun; 107(6):993-1000. PubMed ID: 11398076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cold urticaria as a model of mediator release: platelet factor 4, eosinophil cationic protein and histamine.
    Rosenkranz AR; Wekkeli M; Hippmann G; Benda H; Jarisch R; Götz M
    Allergy; 1992 Aug; 47(4 Pt 2):366-70. PubMed ID: 1280916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mediation of tissue eosinophilia in hypersensitivity reactions. II. Separation of a delayed eosinophil chemotactic factor from macrophage chemotactic factors.
    Hirashima M; Honda M; Hayashi H
    Immunology; 1976 Aug; 31(2):263-71. PubMed ID: 955679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation.
    Puccetti A; Bason C; Simeoni S; Millo E; Tinazzi E; Beri R; Peterlana D; Zanoni G; Senna G; Corrocher R; Lunardi C
    Clin Exp Allergy; 2005 Dec; 35(12):1599-607. PubMed ID: 16393326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells.
    Asero R; Lorini M; Chong SU; Zuberbier T; Tedeschi A
    Clin Exp Allergy; 2004 Jul; 34(7):1111-4. PubMed ID: 15248858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.